Senna Laxative Tablets Recalled for Containing Naproxen Sodium
Magno Humphries Laboratories is recalling Senna Laxative tablets that were mislabeled and contained Naproxen Sodium instead.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The recall is classified as FDA Class I, which is the highest severity level indicating a reasonable probability that use of the product will cause serious adverse health consequences or death.
Plain-English summary
Magno Humphries Laboratories, Inc. is recalling 2,400 bottles of Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles. The product was manufactured for Basic Drugs, Inc. and distributed nationwide in the USA. The specific lot affected is # 352300 with an expiration date of 01/19.
The recall was initiated due to a labeling error where a customer complaint indicated that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg. This mix-up poses a risk to consumers who may inadvertently ingest the wrong medication.
Consumers who have purchased this product should check their bottles for the specific lot number and expiration date listed above. If the product matches the description, consumers should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- Senna Laxative (sennosides) tablets, 8.6 mg, 100-count bottles, Manufactured for: Basic Drugs, Inc., Vandalia, Ohio 45377, UPC Code 3 07610 22020 1.
- Manufacturer
- Magno Humphries Laboratories, Inc
- Category
- Drug — Tablets
- Affected units
- 2,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 352300
- Exp 01/19
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Magno Humphries Laboratories, Inc
See all →- ModerateVitamin E Softgels Recalled for Labeling Discrepancy
FDA (Food) · 2014-04-23
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateGlenmark Recalls Naproxen Sodium Tablets Due to Labeling Error
FDA (Drugs) · 2012-10-03
- HighPrescription Naproxen 250mg tablets recalled for labeling mix-up with indomethacin
FDA (Drugs) · 2023-12-06
- LowHealth Plus Super Colon Cleanse Recalled for Labeling Error
FDA (Drugs) · 2012-07-11
- ModerateNaproxen Sodium Tablets Recall Due to Manufacturing Quality Deviations
FDA (Drugs) · 2021-09-08
- ModerateNaproxen Sodium tablets recalled due to manufacturing compliance deviations
FDA (Drugs) · 2025-04-16
- ModerateAssured Naproxen Sodium Tablets Recalled Due to Mispackaging Error
FDA (Drugs) · 2014-11-19